281 related articles for article (PubMed ID: 23891973)
21. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
[TBL] [Abstract][Full Text] [Related]
22. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Illemann M; Bird N; Majeed A; Sehested M; Laerum OD; Lund LR; Danø K; Nielsen BS
Mol Cancer Res; 2006 May; 4(5):293-302. PubMed ID: 16687484
[TBL] [Abstract][Full Text] [Related]
23. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
24. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
25. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
[TBL] [Abstract][Full Text] [Related]
26. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
28. Proteolytic activation of alternative CCR1 ligands in inflammation.
Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
[TBL] [Abstract][Full Text] [Related]
29. [The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma].
Duan GJ; Yan XC; Bian XW; Li J; Chen X
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):518-22. PubMed ID: 15634446
[TBL] [Abstract][Full Text] [Related]
30. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis.
Rubie C; Oliveira V; Kempf K; Wagner M; Tilton B; Rau B; Kruse B; Konig J; Schilling M
Tumour Biol; 2006; 27(3):166-74. PubMed ID: 16641550
[TBL] [Abstract][Full Text] [Related]
31. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.
Spaderna S; Schmalhofer O; Hlubek F; Berx G; Eger A; Merkel S; Jung A; Kirchner T; Brabletz T
Gastroenterology; 2006 Sep; 131(3):830-40. PubMed ID: 16952552
[TBL] [Abstract][Full Text] [Related]
32. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
33. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer.
Lin BR; Chang CC; Che TF; Chen ST; Chen RJ; Yang CY; Jeng YM; Liang JT; Lee PH; Chang KJ; Chau YP; Kuo ML
Gastroenterology; 2005 Jan; 128(1):9-23. PubMed ID: 15633118
[TBL] [Abstract][Full Text] [Related]
34. Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma.
Barrio-Alonso C; Nieto-Valle A; García-Martínez E; Gutiérrez-Seijo A; Parra-Blanco V; Márquez-Rodas I; Avilés-Izquierdo JA; Sánchez-Mateos P; Samaniego R
J Pathol; 2024 Apr; 262(4):495-504. PubMed ID: 38287901
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L
Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052
[TBL] [Abstract][Full Text] [Related]
36. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Kim J; Mori T; Chen SL; Amersi FF; Martinez SR; Kuo C; Turner RR; Ye X; Bilchik AJ; Morton DL; Hoon DS
Ann Surg; 2006 Jul; 244(1):113-20. PubMed ID: 16794396
[TBL] [Abstract][Full Text] [Related]
37. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
[TBL] [Abstract][Full Text] [Related]
38. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.
Holloway S; Davis M; Jaber R; Fleming J
Int J Gastrointest Cancer; 2003; 33(1):61-9. PubMed ID: 12909738
[TBL] [Abstract][Full Text] [Related]
39. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
Macartney-Coxson DP; Hood KA; Shi HJ; Ward T; Wiles A; O'Connor R; Hall DA; Lea RA; Royds JA; Stubbs RS; Rooker S
BMC Cancer; 2008 Jul; 8():187. PubMed ID: 18590575
[TBL] [Abstract][Full Text] [Related]
40. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells.
Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS
Front Immunol; 2020; 11():570683. PubMed ID: 33424832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
